Literature DB >> 11813171

Supratentorial embryonal tumors in children under 5 years of age: an SFOP study of treatment with postoperative chemotherapy alone.

P Marec-Berard1, A Jouvet, P Thiesse, C Kalifa, F Doz, D Frappaz.   

Abstract

BACKGROUND: To determine the effectiveness of multiagent chemotherapy as sole post-operative treatment of supratentorial central nervous system (CNS) embryonal tumors in young children. PROCEDURE: The data of 25 children under 5 years of age diagnosed with supratentorial embryonal tumors (17 primitive neuroectodermal tumors, four pinealoblastomas, and four medulloepitheliomas) treated exclusively by postoperative chemotherapy (CT) between 1990 and 1997 were reviewed.
RESULTS: Fifteen tumors were hemispheric and 10 were deeply seated. Four children presented with disseminated leptomeningeal disease. Total resection was performed in nine patients, subtotal in 9, partial in 3, and a diagnostic biopsy only in 2. Two children did not undergo surgery. Twenty-four children relapsed with a median time of 5.5 months. The median overall survival was 12 months, and the 2-, and 5- year survivals were 30 and 14%, respectively. The 2- year disease-free survival was 4%. There was a significantly worse prognosis in patients undergoing incomplete resection and in the group with deeply situated tumors. Four relapses were treated by second surgery followed by high-dose chemotherapy and radiotherapy. Two of them remain in CR2, and all these children are free of late sequelae.
CONCLUSIONS: CT alone failed to maintain disease-free survival in most of the children, although, disease progression was delayed to some extent. Children under 5 years with supratentorial embryonal tumors should undergo total surgical resection if possible. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11813171     DOI: 10.1002/mpo.1277

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  15 in total

1.  High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.

Authors:  Antonio Pérez-Martínez; Alvaro Lassaletta; Marta González-Vicent; Julián Sevilla; Miguel Angel Díaz; Luis Madero
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

Review 2.  Pediatric brain tumors: current treatment strategies and future therapeutic approaches.

Authors:  Sabine Mueller; Susan Chang
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 3.  Treatment outcome and patterns of failure in patients of pinealoblastoma: review of literature and clinical experience from a regional cancer centre in north India.

Authors:  Ahitagni Biswas; Supriya Mallick; Suvendu Purkait; Ajeet Gandhi; Chitra Sarkar; Manmohan Singh; Pramod Kumar Julka; Goura Kishor Rath
Journal:  Childs Nerv Syst       Date:  2015-06-04       Impact factor: 1.475

4.  The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data.

Authors:  Omar Chamdine; Ghada Ahmad Saad Elhawary; Ahmad Samir Alfaar; Ibrahim Qaddoumi
Journal:  Childs Nerv Syst       Date:  2018-01-03       Impact factor: 1.475

5.  Congenital pineoblastoma and parameningeal rhabdomyosarcoma: concurrent two embryonal tumors in a young infant.

Authors:  Funda Corapçíoğlu; M Memet Ozek; Aydin Sav; Deniz Uren
Journal:  Childs Nerv Syst       Date:  2005-11-09       Impact factor: 1.475

Review 6.  Is there a role for high dose chemotherapy with hematopoietic stem cell rescue in patients with relapsed supratentorial PNET?

Authors:  C P Raghuram; L Moreno; S Zacharoulis
Journal:  J Neurooncol       Date:  2011-08-18       Impact factor: 4.130

Review 7.  Aggressive infantile embryonal tumors.

Authors:  Tobey J MacDonald
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

8.  Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.

Authors:  Carsten Friedrich; André O von Bueren; Katja von Hoff; Nicolas U Gerber; Holger Ottensmeier; Frank Deinlein; Martin Benesch; Robert Kwiecien; Torsten Pietsch; Monika Warmuth-Metz; Andreas Faldum; Joachim Kuehl; Rolf D Kortmann; Stefan Rutkowski
Journal:  Neuro Oncol       Date:  2012-12-07       Impact factor: 12.300

9.  High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors.

Authors:  Antonio Pérez-Martínez; Victor Quintero; Marta González Vicent; Julián Sevilla; Miguel Angel Díaz; Luis Madero
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

10.  New Treatments in Pediatric Brain Tumors.

Authors:  Roger J. Packer; Alyssa Reddy
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.